Clinical Trial Update: An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). [Phase 2]

View source ↗

Summary

Phase 2 trial update reports effectiveness and safety findings for carisbamate (RWJ-333369) in postherpetic neuralgia, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Postherpetic Neuralgia

Drugs mentioned

• carisbamate (carisbamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Postherpetic Neuralgia, Neuralgia | Phase 2 | Status: COMPLETED